Cullinan Oncology, Inc. (CGEM)

NASDAQ: CGEM · IEX Real-Time Price · USD

16.31

-0.42 (-2.51%)

At close: Jul 2, 2024, 4:00 PM

16.49

+0.18 (1.10%)

After-hours: Jul 2, 2024, 5:12 PM EDT

Cullinan Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-153.16	111.21	-65.57	-51.8	-20.66	Upgrade
Depreciation & Amortization	0.31	0.09	0.05	0.06	0.07	Upgrade
Share-Based Compensation	30.44	27.96	24.38	14.91	0.02	Upgrade
Other Operating Activities	-11.86	-265.93	-2.29	7.06	-0.33	Upgrade
Operating Cash Flow	-134.28	-126.66	-43.43	-29.77	-20.9	Upgrade
Capital Expenditures	-0.21	-1.04	0	-0.01	-0.02	Upgrade
Acquisitions	0	275	0	1.45	0	Upgrade
Change in Investments	36.01	-24.98	-333.78	-6.86	-35.38	Upgrade
Investing Cash Flow	35.81	248.98	-333.78	-5.42	-35.4	Upgrade
Share Issuance / Repurchase	38.93	6.02	270.55	138.93	0	Upgrade
Debt Issued / Paid	1.83	0.18	0	0	0	Upgrade
Other Financing Activities	-	-32.13	-1.77	1.21	85.72	Upgrade
Financing Cash Flow	40.75	-25.93	268.78	140.14	85.72	Upgrade
Net Cash Flow	-57.72	96.38	-108.42	104.95	29.42	Upgrade
Free Cash Flow	-134.48	-127.71	-43.43	-29.78	-20.92	Upgrade
Free Cash Flow Margin	-	-	-229.28%	-	-	Upgrade
Free Cash Flow Per Share	-3.24	-2.83	-1.01	-1.50	-3.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).